Continuous Secretin Infusion with Pancreozymin Pretreatment as a Pancreatic Function Test
- 1 January 1976
- journal article
- research article
- Published by Tohoku University Medical Press in The Tohoku Journal of Experimental Medicine
- Vol. 118 (Suppl) , 173-181
- https://doi.org/10.1620/tjem.118.suppl_173
Abstract
A pancreatic function test is examined with the submaximal dose of secretin given by continuous infusion after injection of cholecystokinin-pancreozymin (CCK-PZ) in the submaximal dose. The active elimination of bladder bile by CCK-PZ pretreatment decreased the influence of biliary contamination, and the volume output and the bicarbonate concentration were stabilized by the continuous infusion of secretion. The coefficients of variation in the volume output and the bicarbonate concentration were calculated to be about 15 and 5%, respectively. These variations were considerably smaller than those obtained in the standard secretin test. The present study is expected to improve the diagnostic means for human pancreatic excretory dysfunction.This publication has 7 references indexed in Scilit:
- Studies on the Secretin TestActa Medica Scandinavica, 2009
- Exploration of pancreatic exocrine function by continuous infusion of secretinDigestive Diseases and Sciences, 1968
- RESPONSE TO SECRETIN IN MAN1968
- A Secretin Test with High Doses of Secretin and Correction for Incomplete Recovery of Duodenal JuiceGastroenterology, 1967
- Pancreatic Volume and Bicarbonate Output with Augmented Doses of SecretinGastroenterology, 1965
- Secretin Inactivating Enzyme in Liver.Experimental Biology and Medicine, 1962
- PANCREOZYMIN-SECRETIN TEST - COMBINED STUDY OF SERUM ENZYMES AND DUODENAL CONTENTS IN THE DIAGNOSIS OF PANCREATIC DISEASE1960